The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Kelly Leanne M. since 2007.
This trader's CIK number is 1398278.
At the time of last reporting, Kelly Leanne M. was the Chief Financial Officer of Vallon Pharmaceuticals, Inc.. (stock ticker symbol VLON).
Also see all insider trading activities at Vallon Pharmaceuticals, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2007 | GENR | 0 | $0 | 0 | $0 | 417 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2021 | VLON | 6,250 | $25,174 | 0 | $0 | 0 | $0 |
2. Vallon Pharmaceuticals, Inc. (VLON)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2007-12-11 | GENR | Option Ex | 417 | .00 | 0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2021-06-04 | VLON | Buy | 1,508 | 4.08 | 6,152 |
| 2021-06-03 | VLON | Buy | 1,085 | 4.05 | 4,394 |
| 2021-06-02 | VLON | Buy | 3,657 | 4.00 | 14,628 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Kelly Leanne M. (Chief Financial Officer of Vallon Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.